Similar articles

• The impact of age and high-risk human papillomavirus (hrHPV) status on the prevalence of high-grade cervical intraepithelial neoplasia (CIN2+) in women with persistent hrHPV-positive, cytology-negative screening samples: a prospective cohort study.

  Tidy JA, Lyon R, Ellis K, Macdonald M, Palmer JE. Tidy JA, et al. BJOG. 2020 Sep;127(10):1260-1267. doi: 10.1111/1471-0528.16250. Epub 2020 May 3. BJOG. 2020. PMID: 32279427
• The impact of human papillomavirus type on colposcopy performance in women offered HPV immunisation in a catch-up vaccine programme: a two-centre observational study.

  Munro A, Gillespie C, Cotton S, Busby-Earle C, Kavanagh K, Cuschieri K, Cubie H, Robertson C, Smart L, Pollock K, Moore C, Palmer T, Cruickshank ME. Munro A, et al. BJOG. 2017 Aug;124(9):1394-1401. doi: 10.1111/1471-0528.14563. Epub 2017 Mar 9. BJOG. 2017. PMID: 28102931
• Human papillomavirus test with cytology triage in organized screening for cervical cancer.

  Veijalainen O, Kares S, Kujala P, Tirkkonen M, Vuento R, Kholová I, Luukkaala T, Osuala V, Mäenpää J. Veijalainen O, et al. Acta Obstet Gynecol Scand. 2016 Nov;95(11):1220-1227. doi: 10.1111/aogs.13013. Acta Obstet Gynecol Scand. 2016. PMID: 27591407
• Risk of Cervical Dysplasia After Colposcopy Care and Risk-Informed Return to Population-Based Screening: A Systematic Review.

  Costa-Fagbemi M, Yakubu M, Meggetto O, Moffatt J, Walker MJ, Koné AP, Murphy KJ, Kupets R. Costa-Fagbemi M, et al. J Obstet Gynaecol Can. 2020 May;42(5):607-624. doi: 10.1016/j.jogc.2019.05.017. Epub 2019 Nov 1. J Obstet Gynaecol Can. 2020. PMID: 31679914 Review.
• Clinical inquiries. What is the best approach for patients with ASCUS detected on Pap smear?

  Huntington J, Oliver LM, St Anna L, Hill J. Huntington J, et al. J Fam Pract. 2004 Mar;53(3):240-1. J Fam Pract. 2004. PMID: 15000934 Review. No abstract available.